Long-term response to sunitinib therapy for metastatic renal cell carcinoma Academic Article uri icon

Overview

MeSH Major

  • Angiogenesis Inhibitors
  • Carcinoma, Renal Cell
  • Indoles
  • Kidney Neoplasms
  • Pyrroles

abstract

  • Sunitinib achieves long-term response in a subset of patients with metastatic RCC. Lack of bone metastasis or lung metastasis and good MSKCC risk status may predict long-term response.

publication date

  • September 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3959735

Digital Object Identifier (DOI)

  • 10.1016/j.clgc.2013.04.001

PubMed ID

  • 23707221

Additional Document Info

start page

  • 297

end page

  • 302

volume

  • 11

number

  • 3